Scarica l'app Stockscreener
2.19
2.82%
0.06
Dopo l'orario di chiusura:
2.18
-0.010
-0.46%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AYTU Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.13
Aprire:
$2.135
Volume 24 ore:
20,560
Relative Volume:
0.45
Capitalizzazione di mercato:
$23.51M
Reddito:
$62.64M
Utile/perdita netta:
$-24.56M
Rapporto P/E:
-0.5705
EPS:
-3.8387
Flusso di cassa netto:
$-3.70M
1 W Prestazione:
+0.00%
1M Prestazione:
-14.79%
6M Prestazione:
+8.96%
1 anno Prestazione:
+8.42%
Intervallo 1D:
$2.12
$2.19
Intervallo di 1 settimana:
$1.98
$2.19
Portata 52W:
$1.46
$3.065
Aytu Biopharma Inc Stock (AYTU) Company Profile
Nome
Aytu Biopharma Inc
Settore
Telefono
(720) 437-6580
Indirizzo
7900 E. UNION AVENUE, DENVER
Compare AYTU vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.19 | 22.86M | 62.64M | -24.56M | -3.70M | -3.8387 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Iniziato | Lake Street | Buy |
| 2025-06-30 | Iniziato | Ascendiant Capital Markets | Buy |
| 2021-03-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-29 | Iniziato | H.C. Wainwright | Buy |
Aytu Biopharma Inc Borsa (AYTU) Ultime notizie
Earnings call transcript: Aytu BioPharma Q3 2026 reveals earnings miss By Investing.com - Investing.com Nigeria
Earnings call transcript: Aytu BioPharma Q3 2026 reveals earnings miss - Investing.com
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 - ACCESS Newswire
Pharma firm Aytu BioPharma to present at virtual investor event May 28 - Stock Titan
Aytu outlines $6M-$7M quarterly sales and marketing spend range as EXXUA scripts rise to over 920 in April - MSN
Aytu BioPharma to Participate in September 2022 Investor Conferences - The Chronicle-Journal
Aytu BioPharma, Inc.Common Stock (NQ: AYTU - The Chronicle-Journal
What Aytu Bio AYTU is doing that separates it from the herd Institutional Selling 20260507Expert Trade Signals - Newser
Analysts Expect Breakeven For Aytu BioPharma, Inc. (NASDAQ:AYTU) Before Long - Sahm
AYTU Stock Price, Quote & Chart | AYTU BIOPHARMA INC (NASDAQ:AYTU) - ChartMill
AYTU BIOPHARMA INC | BIG RISK REWARD | AYTU STOCK | AYTU BIOPHARMA STOCK (K8VNph4cYO) - fathomjournal.org
Aytu BioPharma, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Aytu BioPharma Inc (AYTU) Q3 2026 Earnings Call Highlights: Stro - GuruFocus
Is Aytu BioPharma (AYTU) Overvalued After Q3 FY2026 Earnings Mis - GuruFocus
Aytu (AYTU) Reports Strong Q3 Revenue and Positive Launch Moment - GuruFocus
Aytu BioPharma, Inc. (AYTU) reports Q3 loss, tops revenue estimates - MSN
Aytu BioPharma, Inc. (AYTU) Reports Q3 Loss, Tops Revenue Estimates - sharewise.com
Aytu Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Aytu (AYTU) Q3 2026 Earnings Transcript - The Globe and Mail
Full Transcript: Aytu BioPharma Q3 2026 Earnings Call - Yahoo Finance
Aytu BioPharma (NASDAQ:AYTU) Surges 23% as EXXUA Launch Gains Early Traction in Mixed Q3 Results - ChartMill
AYTU BIOPHARMA Q3 EPS USD -0.53 - Moomoo
Aytu BioPharma (AYTU) swings to loss while launching EXXUA and cutting warrant liabilities - Stock Titan
EXXUA launch reshapes Aytu BioPharma (Nasdaq: AYTU) Q3 2026 results - Stock Titan
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results - ChartMill
MSN Money - MSN
Aytu BioPharma Q3 Earnings Announcement Scheduled - Intellectia AI
Aytu Biopharma Inc expected to post a loss of 51 cents a shareEarnings Preview - TradingView
AYTU: Aytu BioPharma, Inc.Interactive Chart - Zacks Investment Research
What Aytu Bio (AYTU) is doing that separates it from the herd (Institutional Selling) 2026-05-07AI Powered Stock Picks - newser.com
Number of shareholders of Aytu BioPharma, Inc. – LS:A3D38R - TradingView
Aytu BioPharma sets May 13 Q3 2026 results call after close - Stock Titan
Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026 - ACCESS Newswire
Favourable Signals For Aytu BioPharma: Numerous Insiders Acquired Stock - Yahoo Finance
Aytu BioPharma, Inc. (AYTU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
EPS Watch: Is Aytu BioPharma Inc forming a double bottom2026 Stock Rankings & Reliable Entry Point Trade Alerts - baoquankhu1.vn
AYTU Stock Analysis: Aytu BioPharma Inc. biotech stock at 2.68 posts 1.52 percent daily gain - Cổng thông tin điện tử tỉnh Lào Cai
Aytu BioPharma amends warrants to address accounting classification - Investing.com
Aytu BioPharma amends warrants to address accounting classification By Investing.com - Investing.com Canada
Aytu BioPharma Amends Investor Warrants to Restore Equity Classification and Reduce Liabilities - TradingView — Track All Markets
Aytu BioPharma (NASDAQ: AYTU) rewrites warrant terms to restore equity - Stock Titan
Aytu BioPharma Inc (AY20.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
AYTU PE Ratio & Valuation, Is AYTU Overvalued - Intellectia AI
What analysts say about Aytu BioPharma Inc stock2026 Support & Resistance & Weekly Top Stock Performers List - baoquankhu1.vn
Aytu Biopharma Inc Azioni (AYTU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.92%
4.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):